Aphrodisiac Effectiveness of 70% Ethanol Extract of Caulis Lelak (Uvaria rufa Blume.) on Male Mice (Mus musculus)
Abstract
Sexual desire (SD) is often considered normal, but many men lose their sexual life due to poor health conditions. Erectile dysfunction (ED), commonly called impotence, is a condition of sexual dysfunction in the process of male sexual activity. The use of common therapies such as phosphodiesterase-5 (PDE5) inhibition will cause long-term side effects, so alternatives are needed to overcome it. One natural solution that has the potential as an aphrodisiac is Lelak (Uvaria rufa), a plant that is traditionally used by the people of East Nusa Tenggara, Indonesia, to overcome male sexual dysfunction. This study aims to evaluate the safety and effectiveness of U. rufa caulis extract as an aphrodisiac through acute toxicity tests and in vivo testing. The 70% ethanol extract of U. rufa caulis (EeUrC), obtained through the maceration method, was evaluated for its toxicity based on the level of mortality in zebrafish embryos referring to OECD Guideline No. 236, and its aphrodisiac activity was measured through testicular weight parameters and the number of Leydig cells (LC). The results showed that the LD50 of EeUrC was 1096.7 μg/ml, which indicated relatively harmless (>1000 μg/ml), while (AA3) a dose of 1.7 mg/20 g BW of mice body weight per day was stated as the optimal dose for aphrodisiac activity. In conclusion, EeUrC is safe with mild toxicity and effective at optimal doses as an aphrodisiac.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.